{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:06:43Z","timestamp":1779858403035,"version":"3.53.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.placenta.2025.07.075","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:19:51Z","timestamp":1752625191000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MALAT1 overexpression contributes to choriocarcinoma by binding with RBM10 and promoting p53 degradation"],"prefix":"10.1016","volume":"170","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panhong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3898-2970","authenticated-orcid":false,"given":"Xiaohui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2025.07.075_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bpobgyn.2020.12.001","article-title":"Clinical presentation and diagnosis of gestational trophoblastic disease","volume":"74","author":"Lok","year":"2021","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.placenta.2025.07.075_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2478\/raon-2022-0038","article-title":"Advances in diagnostics and management of gestational trophoblastic disease","volume":"56","author":"Lukinovic","year":"2022","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.placenta.2025.07.075_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/14796694.5.2.217","article-title":"Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectives","volume":"5","author":"Cheung","year":"2009","journal-title":"Future Oncol."},{"key":"10.1016\/j.placenta.2025.07.075_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2025.07.075_bib5","article-title":"MALAT1 long non-coding RNA: functional implications","volume":"6","author":"Arun","year":"2020","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.placenta.2025.07.075_bib6","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1080\/15476286.2017.1358347","article-title":"The long noncoding RNA Malat1: its physiological and pathophysiological functions","volume":"14","author":"Zhang","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.placenta.2025.07.075_bib7","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","article-title":"Long noncoding RNA MALAT1 suppresses breast cancer metastasis","volume":"50","author":"Kim","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.placenta.2025.07.075_bib8","first-page":"9025","article-title":"LncRNA MALAT1 regulates proliferation and apoptosis of vascular smooth muscle cells by targeting miRNA-124-3p\/PPARalpha axis","volume":"23","author":"Cheng","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.placenta.2025.07.075_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.molcel.2010.08.011","article-title":"The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation","volume":"39","author":"Tripathi","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.placenta.2025.07.075_bib10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.15252\/embr.201643370","article-title":"The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1","volume":"18","author":"Pruszko","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.placenta.2025.07.075_bib11","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1159\/000495083","article-title":"MALAT1 activates the P53 signaling pathway by regulating MDM2 to promote Ischemic stroke","volume":"50","author":"Zhang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.placenta.2025.07.075_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.biopha.2017.10.083","article-title":"The long non-coding RNA MALAT1 interacted with miR-218 modulates choriocarcinoma growth by targeting Fbxw8","volume":"97","author":"Shi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.placenta.2025.07.075_bib13","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1093\/nar\/gkr1056","article-title":"Functional mammalian spliceosomal complex E contains SMN complex proteins in addition to U1 and U2 snRNPs","volume":"40","author":"Makarov","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.placenta.2025.07.075_bib14","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/MCB.05266-11","article-title":"Semiquantitative proteomic analysis of the human spliceosome via a novel two-dimensional gel electrophoresis method","volume":"31","author":"Agafonov","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.placenta.2025.07.075_bib15","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/sj.emboj.7601631","article-title":"Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes","volume":"26","author":"Behzadnia","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.placenta.2025.07.075_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature06842","article-title":"Isolation of an active step I spliceosome and composition of its RNP core","volume":"452","author":"Bessonov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.placenta.2025.07.075_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/kjm2.12127","article-title":"Alternative splicing of VEGFA is regulated by RBM10 in endometrial cancer","volume":"36","author":"Dou","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.placenta.2025.07.075_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41388-019-1034-9","article-title":"RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53","volume":"39","author":"Jung","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.placenta.2025.07.075_bib19","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/s41375-018-0104-2","article-title":"Targeting the MALAT1\/PARP1\/LIG3 complex induces DNA damage and apoptosis in multiple myeloma","volume":"32","author":"Hu","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.placenta.2025.07.075_bib20","article-title":"Ultraviolet (UV) cross-linking of live cells, lysate preparation, and RNase titration for cross-linking immunoprecipitation (CLIP)","volume":"2018","author":"Darnell","year":"2018","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.placenta.2025.07.075_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020327","article-title":"Regulation of p53 function by formation of non-nuclear heterologous protein complexes","volume":"12","author":"Zavileyskiy","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.placenta.2025.07.075_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ijc.31386","article-title":"A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers, International journal of cancer","volume":"143","author":"Kwok","year":"2018","journal-title":"J. Int. Cancer"},{"key":"10.1016\/j.placenta.2025.07.075_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fgene.2017.00208","article-title":"Identification of minimal p53 promoter region regulated by MALAT1 in human lung adenocarcinoma cells","volume":"8","author":"Tano","year":"2017","journal-title":"Front. Genet."},{"key":"10.1016\/j.placenta.2025.07.075_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.placenta.2025.07.075_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","article-title":"MDM2, MDMX and p53 in oncogenesis and cancer therapy","volume":"13","author":"Wade","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.placenta.2025.07.075_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/387299a0","article-title":"Regulation of p53 stability by Mdm2","volume":"387","author":"Kubbutat","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.placenta.2025.07.075_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: the growing complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.placenta.2025.07.075_bib28","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1101\/gad.8.15.1739","article-title":"Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential","volume":"8","author":"Barak","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.placenta.2025.07.075_bib29","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1593\/neo.121534","article-title":"p53-independent roles of MDM2 in NF-kappaB signaling: implications for cancer therapy, wound healing, and autoimmune diseases","volume":"14","author":"Thomasova","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.placenta.2025.07.075_bib30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/sj.onc.1208323","article-title":"Direct transcriptional regulation of MDM2 by Fli-1","volume":"24","author":"Truong","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.placenta.2025.07.075_bib31","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2174\/187152009789124628","article-title":"Recent advances in validating MDM2 as a cancer target","volume":"9","author":"Rayburn","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.placenta.2025.07.075_bib32","doi-asserted-by":"crossref","first-page":"30468","DOI":"10.1074\/jbc.M112.373738","article-title":"Transcription factor NFAT1 activates the mdm2 oncogene independent of p53","volume":"287","author":"Zhang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.placenta.2025.07.075_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(00)00123-9","article-title":"Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF","volume":"103","author":"Ries","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.placenta.2025.07.075_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/onc.2012.28","article-title":"Loss of microRNA-143\/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop","volume":"32","author":"Zhang","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.placenta.2025.07.075_bib35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jnci\/djt003","article-title":"The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression","volume":"105","author":"Dar","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.placenta.2025.07.075_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1303151","article-title":"LncRNA-miRNA-mRNA regulatory networks in skin aging and therapeutic potentials","volume":"14","author":"Kim","year":"2023","journal-title":"Front. Physiol."},{"key":"10.1016\/j.placenta.2025.07.075_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s10020-022-00516-2","article-title":"MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy","volume":"28","author":"Matuszyk","year":"2022","journal-title":"Mol. Med."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425003078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425003078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:50:43Z","timestamp":1779857443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400425003078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":37,"alternative-id":["S0143400425003078"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2025.07.075","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MALAT1 overexpression contributes to choriocarcinoma by binding with RBM10 and promoting p53 degradation","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2025.07.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}